Literature DB >> 25725582

External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.

Enrique Soto-Pedre1, Jose A Pinies2, Maria C Hernaez-Ortega3.   

Abstract

AIMS: To validate a sight-threatening diabetic retinopathy (STDR) risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus.
METHODS: Retrospective follow-up study of patients with diabetes mellitus attending a diabetes center. Anonimyzed data on gender, type and duration of diabetes, HbA1c, blood pressure and the presence and grade of diabetic retinopathy were gathered to estimate risk for STDR for each individual's worse eye over time by means of a prediction model. Receiver operating characteristics (ROC) analysis was performed to determine the diagnostic ability of the model, and a calibration graph was done to see the model fit.
RESULTS: 508 screening intervals were analyzed, median diabetes duration was 10years, 87% were type 2 diabetes mellitus, and 3.1% developed STDR before the next screening visit. The area under the ROC curve was 0.74, and the calibration graph showed that model had a good fit. The reduction in screening frequency was 40% compared with fixed annual screening.
CONCLUSIONS: Current prediction model used to estimate the risk of developing STDR in patients with diabetes performed well. A personalized screening frequency for diabetic retinopathy could be implemented in practice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes management algorithm; Diabetes mellitus; Diabetic retinopathy; Fundus examination; Screening; Validation study

Mesh:

Year:  2015        PMID: 25725582     DOI: 10.1016/j.jdiacomp.2014.12.020

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  12 in total

1.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  Prognostic prediction models for diabetic retinopathy progression: a systematic review.

Authors:  Sajjad Haider; Salman Naveed Sadiq; David Moore; Malcolm James Price; Krishnarajah Nirantharakumar
Journal:  Eye (Lond)       Date:  2019-01-16       Impact factor: 3.775

3.  Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.

Authors:  S H Lund; T Aspelund; P Kirby; G Russell; S Einarsson; O Palsson; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2015-09-16       Impact factor: 4.638

4.  High -density lipoprotein cholesterol as a predictor for diabetes mellitus.

Authors:  Hong Wu; Peng Ouyang; Wenjun Sun
Journal:  Caspian J Intern Med       Date:  2018

Review 5.  The unmet need for better risk stratification of non-proliferative diabetic retinopathy.

Authors:  S Sivaprasad; E Pearce
Journal:  Diabet Med       Date:  2018-12-07       Impact factor: 4.359

6.  Nomogram for Prediction of Diabetic Retinopathy Among Type 2 Diabetes Population in Xinjiang, China.

Authors:  Yongsheng Li; Cheng Li; Shi Zhao; Yi Yin; Xueliang Zhang; Kai Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-07       Impact factor: 3.168

7.  Real-world outcomes of a clinical decision support system for diabetic retinopathy in Spain.

Authors:  Pedro Romero-Aroca; Raquel Verges; Najlaa Maarof; Aida Vallas-Mateu; Alex Latorre; Antonio Moreno-Ribas; Ramon Sagarra-Alamo; Josep Basora-Gallisa; Julian Cristiano; Marc Baget-Bernaldiz
Journal:  BMJ Open Ophthalmol       Date:  2022-03-28

Review 8.  Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting.

Authors:  Amber A van der Heijden; Giel Nijpels; Fariza Badloe; Heidi L Lovejoy; Linda M Peelen; Talitha L Feenstra; Karel G M Moons; Roderick C Slieker; Ron M C Herings; Petra J M Elders; Joline W Beulens
Journal:  Diabetologia       Date:  2020-04-03       Impact factor: 10.122

9.  A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective.

Authors:  Sajad Emamipour; Amber A W A van der Heijden; Giel Nijpels; Petra Elders; Joline W J Beulens; Maarten J Postma; Job F M van Boven; Talitha L Feenstra
Journal:  Diabetologia       Date:  2020-07-31       Impact factor: 10.122

10.  Prognostic models of diabetic microvascular complications: a systematic review and meta-analysis.

Authors:  Sigit Ari Saputro; Oraluck Pattanaprateep; Anuchate Pattanateepapon; Swekshya Karmacharya; Ammarin Thakkinstian
Journal:  Syst Rev       Date:  2021-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.